Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.64 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.53 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.52 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
| ▸ | LTA4H | P09960 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14640803 | 0.98 | GPR84 (0.68) | GPR84TRPV1FFAR1FFAR4NFKB1 | |
| SCHEMBL17002061 | 0.98 | GPR84 (0.68) | GPR84TRPV1FFAR1FFAR4NFKB1 | |
| SCHEMBL11735870 | 0.84 | GPR84 (0.43) | GPR84TRPV1FFAR1FFAR4NFKB1 | |
| SCHEMBL8817418 | 0.83 | GPR84 (0.66) | GPR84TRPV1FFAR1FFAR4NFKB1 | |
| SCHEMBL9449753 | 0.83 | GPR84 (0.66) | GPR84TRPV1FFAR1FFAR4NFKB1 | |
| SCHEMBL23728321 | 0.83 | GPR84 (0.60) | GPR84TRPV1FFAR1FFAR4NFKB1 | |
| SCHEMBL12396669 | 0.83 | GPR84 (0.66) | GPR84TRPV1FFAR1FFAR4NFKB1 | |
| SCHEMBL12419013 | 0.83 | GPR84 (0.66) | GPR84TRPV1FFAR1FFAR4NFKB1 | |
| SCHEMBL27968594 | 0.83 | GPR84 (0.44) | GPR84TRPV1FFAR1FFAR4NFKB1 | |
| SCHEMBL23728329 | 0.82 | GPR84 (0.63) | GPR84TRPV1FFAR1FFAR4NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030092599-A1 | Fragrance and flavor compositions and fragrance- and flavor-added products | TAKASAGO INTERNATIONAL CORPORATION | 2003-05-15 | — | — | US | claimed |
| US-20030092599-A1 | Fragrance and flavor compositions and fragrance- and flavor-added products | TAKASAGO INTERNATIONAL CORPORATION | 2003-05-15 | — | — | US | disclosed |
| US-4346025-A | Stabilized vinyl chloride polymer comprising a phenylethylidene aryl phosphite | ADEKA ARGUS CHEMICAL CO., LTD. (JP) | 1982-08-24 | — | — | US | disclosed |
| US-4224203-A | Vinyl chloride polymer stabilizer comprising a metal organophosphonate | ARGUS CHEMICAL CORPORATION (US) | 1980-09-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030092599-A1 | Fragrance and flavor compositions and fragrance- and flavor-added products | FAAH, KISS1R, DOHH | GPR84 93/4885TRPV1 127/4885FFAR1 45/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.